Alternatives to DenovAI Biotech

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-driven digital twin of embryo development for cell-based therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Developing novel therapeutics for rare genetic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.